Back to Rhode Island

H8382 • 2026

AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- PHARMACIES (Strengthens enforcement of the state's pharmacy audit law by clarifying and tightening audit procedures to ensure pharmacy audits are conducted fairly and transparently.)

AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- PHARMACIES (Strengthens enforcement of the state's pharmacy audit law by clarifying and tightening audit procedures to ensure pharmacy audits are conducted fairly and transparently.)

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Kislak, McGaw, Donovan, Corvese, Cruz, Giraldo, Potter, Fogarty, Stewart
Last action
2026-04-14
Official status
Committee recommended measure be held for further study
Effective date
Not listed

Plain English Breakdown

The plain English breakdown is still being put together. The official documents below are already here.

Bill History

  1. 2026-04-14 Committee

    Committee recommended measure be held for further study

  2. 2026-04-10 Rhode Island General Assembly

    Scheduled for hearing and/or consideration (04/14/2026)

  3. 2026-04-01 Rhode Island General Assembly

    Introduced, referred to House Health & Human Services

Official Summary Text

AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- PHARMACIES (Strengthens enforcement of the state's pharmacy audit law by clarifying and tightening audit procedures to ensure pharmacy audits are conducted fairly and transparently.)

Current Bill Text

Read the full stored bill text
H8382

2026 -- H 8382
========
LC006204
========

STATE OF RHODE ISLAND
IN GENERAL ASSEMBLY
JANUARY SESSION, A.D. 2026
____________
A N A C T
RELATING TO BUSINESSES AND PROFESSIONS -- PHARMACIES

Introduced By:
Representatives Kislak, McGaw, Donovan, Corvese, Cruz, Giraldo,
Potter, Fogarty, and Stewart

Date Introduced:
April 01, 2026

Referred To:
House Health & Human Services
(Attorney General)
It is enacted by the General Assembly as follows:
1
SECTION 1. Section 5-19.1-35 of the General Laws in Chapter 5-19.1 entitled
2
"Pharmacies" is hereby amended to read as follows:
3

5-19.1-35. Audits.
4
(a)
For the purposes of this section:
5

(1) “Audit” means a systematic review of provider claims, documentation, and billing
6
practices, whether conducted remotely or on site, for the purported purpose of ensuring payments
7
are made for covered, reasonable, and necessary services, or to detect fraud, waste, and abuse, or
8
to recover overpayments.
9

(2) “Auditor” means a person or entity who conducts an audit as defined in subsection
10
(a)(1) of this section.
11

(b)
When an
on-site
audit of the records of a pharmacy is conducted by a carrier or its
12
intermediary, the audit must be conducted in accordance with the following criteria:
13
(1) A finding of overpayment or underpayment must be based on the actual overpayment
14
or underpayment, and not a projection based on the number of patients served having a similar
15
diagnosis, or on the number of similar orders or refills for similar drugs, unless the projected
16
overpayment or denial is a part of a settlement agreed to by the pharmacy or pharmacist;
17
(2) The auditor may not use extrapolation in calculating recoupments or penalties unless
18
required by state or federal laws or regulations;
19
(3) Any audit that involves clinical judgment must be conducted by, or in consultation with,

1
a pharmacist; and
2
(4) Each entity conducting an audit shall establish an appeal process under which a
3
pharmacy may appeal an unfavorable preliminary audit report to the entity.
4

(b) This section does not apply to any audit, review, or investigation that is initiated based
5
on or involving suspected or alleged fraud, willful misrepresentation, or abuse.
6
(c) Prior to an audit, the entity conducting an audit shall give the pharmacy fourteen (14)
7
days advance written notice of the audit and the range of prescription numbers involved in the audit.
8
The carrier or its intermediary may mask the last two digits of the numbers. Additionally, the
9
number of prescriptions shall not exceed one hundred fifty (150) prescription claims and their
10
applicable refills. The time allotted must be adequate to collect all samples. The examination of
11
signature logs shall not exceed twenty-five (25) signature logs in number.
12
(d) A pharmacy has the right to execute the dispute resolution contained in their contract.
13
(e)(1) A preliminary audit report must be delivered to the pharmacy or its corporate office
14
within sixty (60) days after the conclusion of the audit. A pharmacy must be allowed at least thirty
15
(30) days following receipt of the preliminary audit
report
to provide documentation to address any
16
discrepancy found in the audit. A final audit report must be delivered to the pharmacy or its
17
corporate office within ninety (90) days after receipt of the preliminary audit report or final appeal,
18
whichever is later. A charge-back recoupment or other penalty may not be assessed until the appeal
19
process provided by the pharmacy benefits manager has been exhausted and the final report issued.
20
If the identified discrepancy for a single audit exceeds twenty-five thousand dollars ($25,000),
21
future payments in excess of that amount may be withheld pending the adjudication of an appeal.
22
Auditors shall only have access to previous audit reports on a particular pharmacy conducted for
23
the same entity.
24

(2) Auditors may initiate a desk audit prior to an on-site audit unless otherwise specified in
25
the law.
26

(3)
(2)
Contracted auditors cannot be paid based on the findings within an audit.
27

(4)
(3)
Scanned images of all prescriptions including all scheduled controlled substances
28
are allowed to be used by the pharmacist for an audit. Verbally received prescriptions must be
29
accepted upon validation by the auditing entity and applicable for the
initial desk or on-site
audit.
30

(5)
(4)
The period covered by an audit may not exceed two (2) years.
31

(6)
(5)
Within five (5) business days of receiving the audit notification, pharmacies are
32
allowed, at a minimum, one opportunity to reschedule with the auditor if the scheduled audit
33
presents a scheduling conflict for the pharmacist.
34
(f) Any clerical error, typographical error, scrivener’s error, or computer error regarding a

LC006204 - Page 2 of 5
1
document or record does not constitute a willful violation and is not subject to criminal penalties
2
without proof of intent to commit fraud.
3
(g)
Limitations.
4
(1)
Exceptions.

The

Subject to subsection (g)(2) of this section, the
provisions of this
5
chapter do not apply to an investigative audit of pharmacy records when:
6
(i) Fraud, waste, abuse, or other intentional misconduct is indicated by physical review or
7
review of claims data or statements; or
8
(ii) Other investigative methods indicate a pharmacy is or has been engaged in criminal
9
wrongdoing, fraud, or other intentional or willful misrepresentation.
10

(2) Scope of exceptions.
11

(i) An audit for which an exception is applicable shall be strictly limited in scope to the
12
issue(s) directly giving rise to the suspicions, allegations, or conduct indicated by other
13
investigative methods. Before conducting an audit for which an exception is applicable, the auditor
14
shall memorialize in writing the basis for any exception hereunder, which shall include a
15
description of the specific issue(s) under review and facts giving rise to the audit, and shall make
16
such writing available to the attorney general upon request.
17

(ii) The auditor may not rely solely on a finding of common control or common ownership
18
as a basis for conducting an audit to which an exception applies with respect to a pharmacy, unless
19
the auditor first confirms the presence of an identified systemic error, fraud, abuse, willful
20
misrepresentation, or criminal wrongdoing with respect to a pharmacy under common control or
21
common ownership.
22

(2)
(3)

Frequency of audits.
A pharmacy shall not be subject to more than one
on-site
audit
23
in connection with a carrier every twelve (12) months, unless there is an identified problem or
24
substantial evidence of
fraud
, abuse,

or
misrepresentation
is suspected
, or other criminal
25
wrongdoing
.
26

(3)
(4)

Federal law.
This chapter does not supersede any audit requirements established by
27
federal law.
28

(5) Notice to the attorney general. Prior to initiating an audit pursuant to an exception under
29
subsection (g)(1) of this section, the auditor shall provide written notice to the attorney general of
30
their intent to conduct an audit pursuant to an applicable exception. Such notice shall be provided
31
at least three (3) business days prior to the initiation of the audit.
32
(h)
Enforcement.
The
Rhode Island
attorney general shall have the authority to enforce
33
and ensure compliance with this section.
34

(1) The attorney general may institute proceedings to prevent and restrain violations of this

LC006204 - Page 3 of 5
1
section. The superior court shall have jurisdiction to prevent and restrain violations of this section.
2

(2) In addition to injunctive relief, any person or entity in violation of this section shall be
3
liable for a civil penalty, in an action brought by the attorney general, of not more than ten thousand
4
dollars ($10,000) for each violation.
5

(3) The attorney general may promulgate rules and regulations to implement the provisions
6
of this section.
7
SECTION 2. This act shall take effect upon passage.
========
LC006204
========

LC006204 - Page 4 of 5
EXPLANATION
BY THE LEGISLATIVE COUNCIL
OF
A N A C T
RELATING TO BUSINESSES AND PROFESSIONS -- PHARMACIES
***
1
This act would strengthen enforcement of the state's pharmacy audit law by clarifying and
2
tightening audit procedures to ensure pharmacy audits are conducted fairly and transparently.
3
This act would take effect upon passage.
========
LC006204
========

LC006204 - Page 5 of 5